http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101857246-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4747 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-705 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-85 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1761 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-177 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0645 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-85 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0786 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705 |
filingDate | 2015-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2018-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2018-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-101857246-B1 |
titleOfInvention | Artificial apoptotic cell receptor and uses thereof |
abstract | The present invention relates to a pharmaceutical composition for preventing or treating an autoinflammatory cell receptor and a chronic inflammatory or autoimmune disease comprising said receptor. The artificial apoptotic cell receptor according to the present invention can act specifically on the apoptotic cell without activating signal transduction inside the cell, thereby promoting the apoptotic cell removal action. Therefore, the chronic apoptotic cell receptor according to the present invention, A pharmaceutical composition for preventing or treating diseases, or a cell therapy agent for treating chronic inflammation or autoimmune disease. |
priorityDate | 2015-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 330.